These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Kent JD; Blader JC; Koplewicz HS; Abikoff H; Foley CA Pediatrics; 1995 Aug; 96(2 Pt 1):320-5. PubMed ID: 7630692 [TBL] [Abstract][Full Text] [Related]
5. Response to methylphenidate in children with ADHD and comorbid anxiety. Diamond IR; Tannock R; Schachar RJ J Am Acad Child Adolesc Psychiatry; 1999 Apr; 38(4):402-9. PubMed ID: 10199111 [TBL] [Abstract][Full Text] [Related]
6. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder? Law SF; Schachar RJ J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):944-51. PubMed ID: 10434485 [TBL] [Abstract][Full Text] [Related]
7. Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD. Rösler M; Retz W; Fischer R; Ose C; Alm B; Deckert J; Philipsen A; Herpertz S; Ammer R World J Biol Psychiatry; 2010 Aug; 11(5):709-18. PubMed ID: 20353312 [TBL] [Abstract][Full Text] [Related]
8. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder. Pelham WE; Gnagy EM; Chronis AM; Burrows-MacLean L; Fabiano GA; Onyango AN; Meichenbaum DL; Williams A; Aronoff HR; Steiner RL Pediatrics; 1999 Dec; 104(6):1300-11. PubMed ID: 10585981 [TBL] [Abstract][Full Text] [Related]
9. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children]. Pan XX; Ma HW; Wan B; Dai XM Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164 [TBL] [Abstract][Full Text] [Related]
11. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings. Kolko DJ; Bukstein OG; Barron J J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190 [TBL] [Abstract][Full Text] [Related]
12. A dose-ranging study of a methylphenidate transdermal system in children with ADHD. Pelham WE; Manos MJ; Ezzell CE; Tresco KE; Gnagy EM; Hoffman MT; Onyango AN; Fabiano GA; Lopez-Williams A; Wymbs BT; Caserta D; Chronis AM; Burrows-Maclean L; Morse G J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):522-9. PubMed ID: 15908834 [TBL] [Abstract][Full Text] [Related]
13. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder. Bukstein OG; Kolko DJ J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data. Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569 [TBL] [Abstract][Full Text] [Related]
15. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069 [TBL] [Abstract][Full Text] [Related]
16. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [TBL] [Abstract][Full Text] [Related]
17. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014 [TBL] [Abstract][Full Text] [Related]
18. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder. Fallu A; Richard C; Prinzo R; Binder C Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338 [TBL] [Abstract][Full Text] [Related]
19. Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Schertz M; Adesman AR; Alfieri NE; Bienkowski RS Pediatrics; 1996 Oct; 98(4 Pt 1):763-9. PubMed ID: 8885958 [TBL] [Abstract][Full Text] [Related]
20. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Steele M; Weiss M; Swanson J; Wang J; Prinzo RS; Binder CE Can J Clin Pharmacol; 2006; 13(1):e50-62. PubMed ID: 16456216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]